Archive for March 2020
Mechanism-based modeling of the effect of a novel inhibitor of vascular adhesion protein-1 on albuminuria and renal function markers in patients with diabetic kidney disease.
Hoefman S., Snelder N., van Noort M., Garcia-Hernandez A., Onkels H., Larsson T.E., Bergmann K.R. Mechanism-based modeling of the effect of a novel inhibitor of vascular adhesion protein-1 on albuminuria and renal function markers in patients with diabetic kidney disease. J Pharmacokinet Pharmacodyn. 2020 [Link to publication]
Read MorePopulation pharmacokinetics and pharmacodynamics of a novel vascular adhesion protein-1 inhibitor using a multiple-target mediated drug disposition model.
Snelder N., Hoefman S., Garcia-Hernandez A., Onkels H., Larsson T.E., Bergmann K.R. Population pharmacokinetics and pharmacodynamics of a novel vascular adhesion protein-1 inhibitor using a multiple-target mediated drug disposition model. J Pharmacokinet Pharmacodyn. 2020 [Link to publication]
Read More